Cantor Fitzgerald Comments on ACAD FY2025 Earnings
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for shares of ACADIA Pharmaceuticals in a report issued on Thursday, June 5th. Cantor Fitzgerald analyst J. Kim anticipates that the biopharmaceutical company will post earnings of $0.51 per share for the year. Cantor […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Equities researchers at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for shares of ACADIA Pharmaceuticals in a report issued on Thursday, June 5th. Cantor Fitzgerald analyst J. Kim anticipates that the biopharmaceutical company will post earnings of $0.51 per share for the year. Cantor […]
